Acute promyelocytic leukemia: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(8 intermediate revisions by 3 users not shown)
Line 16: Line 16:
'''For patient information click [[Leukemia (patient information)|here]]'''
'''For patient information click [[Leukemia (patient information)|here]]'''


{{CMG}}
{{CMG}}; {{AE}} {{S.G.}} {{GRR}} {{Nat}}


{{SK}} Acute progranulocytic leukemia; APL; AML with t(15;17)(q22;q12); PML-RARA and variants; FAB subtype M3; M3 variant
{{SK}} Acute progranulocytic leukemia; APL; AML with t(15;17)(q22;q12); PML-RARA and variants; FAB subtype M3; M3 variant
Line 34: Line 34:
==[[Acute promyelocytic leukemia risk factors|Risk Factors]]==
==[[Acute promyelocytic leukemia risk factors|Risk Factors]]==


==[[Acute promyelocytic leukemia natural history|Natural History, Complications and Prognosis]]==
==[[Acute promyelocytic leukemia natural history, complications and prognosis|Natural History, Complications and Prognosis]]==


==Diagnosis==
==Diagnosis==
[[Acute promyelocytic leukemia history and symptoms|History and Symptoms]] | [[Acute promyelocytic leukemia physical examination|Physical Examination]] | [[Acute promyelocytic leukemia laboratory tests|Laboratory Findings]] | [[Acute promyelocytic leukemia chest x ray|Chest X Ray]] | [[Acute promyelocytic leukemia CT|CT]] | [[Acute promyelocytic leukemia other diagnostic studies|Other Diagnostic Studies]]
[[Acute promyelocytic leukemia history and symptoms|History and Symptoms]] | [[Acute promyelocytic leukemia physical examination|Physical Examination]] | [[Acute promyelocytic leukemia laboratory findings|Laboratory Findings]] | [[Acute promyelocytic leukemia other imaging studies|Other Imaging studies]] | [[Acute promyelocytic leukemia other diagnostic studies|Other Diagnostic Studies]]


==Treatment==
==Treatment==
[[Acute promyelocytic leukemia medical therapy#Overview|Medical Therapy Overview]] | [[Acute promyelocytic leukemia medical therapy#Chemotherapy|Chemotherapy]] | [[Acute promyelocytic leukemia medical therapy#Relapsed AML|Relapsed AML]] | [[Acute promyelocytic leukemia medical therapy#Supportive Therapy|Supportive Therapy]]
[[Acute promyelocytic leukemia medical therapy|Medical Therapy]] | [[Acute promyelocytic leukemia cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Acute promyelocytic leukemia future or investigational therapies|Future or Investigational Therapies]]


==Case Studies==
==Case Studies==
Line 56: Line 56:
[[Category:Oncology]]
[[Category:Oncology]]
[[Category:Overview complete]]
[[Category:Overview complete]]
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Medicine]]
[[Category:Hematology]]
[[Category:Immunology]]

Latest revision as of 14:31, 29 October 2019

Template:DiseaseDisorder infobox

Acute promyelocytic leukemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Acute promyelocytic leukemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Imaging Studies

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary PreventionSurgery

Secondary PreventionSurgery

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Acute promyelocytic leukemia On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Acute promyelocytic leukemia

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Acute promyelocytic leukemia

CDC on Acute promyelocytic leukemia

Acute promyelocytic leukemia in the news

Blogs on Acute promyelocytic leukemia

Directions to Hospitals Treating Acute promyelocytic leukemia

Risk calculators and risk factors for Acute promyelocytic leukemia

For patient information click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sogand Goudarzi, MD [2] Grammar Reviewer: Natalie Harpenau, B.S.[3]

Synonyms and keywords: Acute progranulocytic leukemia; APL; AML with t(15;17)(q22;q12); PML-RARA and variants; FAB subtype M3; M3 variant

Overview

Historical Perspective

Classification

Pathophysiology

Differentiating Acute promyelocytic leukemia from Other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | Other Imaging studies | Other Diagnostic Studies

Treatment

Medical Therapy | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case #1

de:Promyelozytenleukämie

Template:WikiDoc Sources